Different countries take different approaches to rolling out COVID-19 vaccine
Britain on Wednesday became the first country in the world to approve a coronavirus vaccine developed by Oxford University and AstraZeneca as it battles a major winter surge driven by a new, highly contagious variant of the virus.
“The government has today accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorise Oxford University/AstraZeneca’s COVID-19 vaccine for use,” the health ministry said.
The pandemic has already killed 1.7 million people around the world, sown chaos through the global economy and upended normal life for billions since it began in Wuhan, China, a year ago.
[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]
Britain and South Africa in particular are grappling with new variants of the coronavirus, which the government and scientists say are more contagious; many countries have responded by banning passenger flights and blocking trade.
Trending Stories
Remembering the celebrities we lost in 2020
‘The world is never going to forget me,’ suspect in Nashville explosion told neighbour
AstraZeneca and other developers have said they are studying the impact of the new variant but expect that their shots will be effective against it.
Regulatory endorsement is a welcome boost for AstraZeneca and the Oxford team, which have been accused of a lack of clarity about the results from late-stage trials.
The vaccine is one of two candidates currently undergoing a rolling review by Health Canada, along with one developed by Johnson & Johnson.
(Reporting by Alistair Smout; editing by Guy Faulconbridge)
View link »© 2020 Reuters
